Medis Technologies
WKN: 501706, Börse: NASDAQ, Marktkapital. 453,52 Mio. USD
http://www.medistechnologies.com/
- power through proprietary fuel cell technology for portable electronic devices
- cell-based medical diagnostics and research systems
Medis Technologies’ primary focus is on direct liquid fuel cell technology. Its business strategy is to sell its products to end users through retail outlets and service providers. Medis has also developed the CellScan with many potential applications relating to disease diagnostics and chemo sensitivity. Additionally, Medis’ product pipeline includes other technologies, in varying stages of development.
1 Jahr:
3 Monate:
